Effects of chronic treatment with indomethacin at clinically relevant doses on intestinal tissue 6-keto prostaglandin F(1α) and leukotriene B4 level in relation to gastroenteropathy

Inflammation

Volumn 22, Issue 3, 1998, Pages 243-252

  Uçar, Atila ^a   Sak, Serpil Dizbay ^a   Melli, Mehmet ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; INDOMETACIN; LEUKOTRIENE B4; NABUMETONE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENTEROPATHY; ENZYME IMMUNOASSAY; INTESTINE INJURY; INTESTINE ULCER; MALE; MORTALITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PROSTAGLANDIN SYNTHESIS; RAT; STOMACH DISEASE; SURVIVAL TIME; TISSUE LEVEL;

6-KETOPROSTAGLANDIN F1 ALPHA; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BUTANONES; DIGESTIVE SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EATING; FASTING; INDOMETHACIN; INTESTINES; LEUKOTRIENE B4; MALE; RATS; STOMACH; TIME FACTORS;

ANIMALIA;

EID: 0031831874     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022354614385     Document Type: Article

References (30)

1. PRICE, A. H., and M. FLETCHER. 1990. Mechanisms of NSAID-induced gastroenteropathy. Drugs 40:1-11.
2. ROTH, S. H. 1989. New understandings of NSAID gastropathy. Scand. J. Rheum. Suppl. 78:24-29.
3. HUCKER, H. B., A. G. ZACCHEI, S. V. COX, D. A. BRODIE, and N. H. R. CANTWELL. 1966. Studies on the absorption, distribution and excretion of indomethacin in various species. J. Pharmacol. Exp. Ther. 153:237-249.
4. BECK, W. S., H. T. SCHNEIDER, K. DIETZEL, B. NUERNBERG, and K. BRUNE. 1990. Gastrointestinal ulcerations induced by anti-inflammatory drugs in rats. Arch. Toxicol. 64:210-217.
5. HOLLANDER, D. 1994. Gastrointestinal complications of nonsteroidal anti-inflammatory drugs: Prophylactic and therapeutic strategies. Am. J. Med. 96:274-281.
6. KAPUI, Z., K. BOER, I. ROZSA, Gy. BLASKO, and I. HERMECZ. 1993. Investigations of indomethacin-induced gastric ulcers in rats. Arzneim.-Forsch./Drug Res. 43(II):767-771.
7. SATOH, H., I. INADA, T. HIRATA, and Y. MAKI. 1981. Indomethacin produces gastric antral ulcers in the refed rat. Gastroenterology 81:719-725.
8. MELARANGE, R., C. GENTRY, C. O'CONNELL, and P. R. BLOWER. 1991. Anti-inflammatory efficacy and gastrointestinal irritancy: Comparative 1 month repeat oral dose studies in the rat with nabumetone, ibuprofen and diclofenac. Agents Actions (Suppl.) 32:33-37.
9. SHRIVER, D. A., C. B. WHITE, A. SANDOR, and M. E. ROSENTHALE. 1975. A profile of the rat gastrointestinal toxicity of drugs used to treat inflammatory diseases. Toxicol. Appl. Pharmacol. 32:73-83.
10. VANE, J. R. 1971. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231:232-234.
11. LEVINE, R. A., S. PETOKAS, J. NANDI, and D. ENTHOVEN. 1988. Effects of non-steroidal anti-inflammatory drugs on gastro-intestinal injury and prostanoid generation in healthy volunteers. Dig. Dis. Sci. 33:660-666.
12. LIGUMSKI, M., E. M. GOLANSKA, D. G. HANSEN, and G. L. KAUFFMAN. 1983. Aspirin can inhibit gastric mucosal cyclo-oxygenase without causing lesions in the rat. Gastroenterology 84:756-761.
13. BASKIN, W. N., K. J. IVEY, W. J. KRAUSE, G. E. JEFFREY, and R. T. GEMMELL. 1976. Aspirin-induced ultrastructural changes in human gastric mucosa. Ann. Inter. Med. 85:299-303.
14. RAINSFORD, K. D. 1993. Leukotrienes in the pathogenesis of NSAID-induced gastric and intestinal mucosal damage. Agents Actions 39(Special Conference Issue):C24-C26.
15. VAANANEN, P. M., C. M. KEENAN, M. B. GRISHAM. and J. L. WALLACE. 1992. Pharmacological investigation of the role of leukotrienes in the pathogenesis of experimental NSAID gastropathy. Inflammation 16:227-239.
16. 4 production during acute anaphylaxis in sheep. J. Exp. Med. 163:1509-1517.
17. 4 during aspirin-induced asthma. J. Lab. Clin. Med. 119:48-51.
18. 4 synthesis in patients taking NSAIDs. Gut 34:742-747.
19. PRADELLES, P., J. GRASSI, and J. MACLOUF. 1985. Enzyme immunoassay of eicosanoids using AchE as label: An alternative to RIA. Anal. Biochem. 57:467-477.
20. ALLISON, M. C., A. G. HOWATSON, C. J. TORRANCE, F. D. LEE, and R. I. RUSSELL. 1992. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N. Engl. J. Med. 327:749-754.
21. BJARNASON, I., G. ZANELLI, T. SMITH, P. PROUSE, G. DE LACEY, M. J. GUMPEL, and A. J. LEVI. 1987. Non-steroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology 93, 480-489.
22. BJARNASON, I., B. FEHILLY, P. SMETHURST, I. S. MENZIES, and A. J. LEVI. 1991. Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man. Gut 32:275-277.
23. DUGGAN, D. E., and K. C. KWAN. 1979. Enterohepatic recirculation of drugs as a determinant of therapeutic ratio. Drug Metab. Reviews 6:21-41.
24. BRUNE, K., K. DIETZEL, B. NÜRNBERG, and T. SCHNEIDER. 1987. Recent insight into the mechanism of gastrointestinal tract ulceration. Scand. J. Rheum. Suppl. 65:135-140.
25. SCHNEIDER, T., B. NÜRNBERG, K. DIETZEL, and K. BRUNE. 1990. Differences in biliary elimination of non-steroidal anti-inflammatory drugs in patients with percutaneous transhepatic cholangiodrainage. Br. J. Clin. Pharmacol. 129:127-131.
26. BRODIE, D. A., P. G. COOK, B. J. BAUER, and G. E. DAGLE. 1970. Indomethacin-induced intestinal lesions in the rat. Toxicol. Appl. Pharmacol. 17:615-624.
27. WALLACE, J. L. 1994. Mechanism of nonsteroidal anti-inflammatory drugs (NSAID) induced gastrointestinal damage-potential for development of gastrointestinal tract safe NSAIDs. Can. J. Physiol. Pharmacol. 72:1493-1498.
28. BRETT, M. A., W. H. GREB, H. J. KURTH, G. RULANDER, R. E. HADDOCK, and A. R. THAWLEY. 1988. Fehlende enterohepatische zirculation des aktiven metaboliten von nabumetone. Fortschr. Med. 106:736.
29. SANFORD, H. R. 1992. Nabumetone: A new NSAID for rheumatoid arthritis and osteoarthritis. Orthopaedic Review 11:223-227.
30. MELARANGE, R., C. GENTRY, C. O'CONNELL, P. R. BLOWER, C. NEIL, A. S. KELVIN, and C. D. N. TOSELAND. 1992. Antiinflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6-methoxy-2-naphtylacetic acid (6MNA) Comparative studies with indomethacin. Digest. Dis. Sci. 37:1847-1852.